ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MRM vs OCG // EV/EBITDA & P/E VALUATION

MEDIROM Healthcare Technologies Inc. (NASDAQ) VS. Oriental Culture Holding LTD (NASDAQ) • 15-METRIC TALLY: MRM 0 — OCG 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MRM VS. OCG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MRM OCG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 85.70% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -9.40% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — 2.44% — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 180.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 2.22 — TIE /balance-sheet <GO>
Piotroski F-Score Quality — 6/9 — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 23.1 49.2 -26.16 OCG /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.7M $3.2M -$425.4K OCG /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MRM REV OCG REV MRM GROSS % OCG GROSS % MRM FCF OCG FCF
FY 2025 — $1.9M — 85.7% — $77.1K
FY 2024 — $622.7K — 70.7% — -$4.1M
FY 2023 — $1.6M — — — $3.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MRM // BETA —
OCG // BETA —